874 related articles for article (PubMed ID: 21208549)
1. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
[TBL] [Abstract][Full Text] [Related]
2. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
[TBL] [Abstract][Full Text] [Related]
3. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
[TBL] [Abstract][Full Text] [Related]
4. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
5. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
Puleston RL; Bugg G; Hoschler K; Konje J; Thornton J; Stephenson I; Myles P; Enstone J; Augustine G; Davis Y; Zambon M; Nicholson KG; Nguyen-Van-Tam JS
Health Technol Assess; 2010 Dec; 14(55):1-82. PubMed ID: 21208547
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.
Rizzo C; Rota MC; Bella A; Alfonsi V; Declich S; Caporali MG; Ranghiasci A; Lapini G; Piccirella S; Salmaso S; Montomoli E
Vaccine; 2010 Apr; 28(20):3558-62. PubMed ID: 20307592
[TBL] [Abstract][Full Text] [Related]
7. A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart.
Nicholson KG; Abrams KR; Batham S; Clark TW; Hoschler K; Lim WS; Medina M; Nguyen-Van-Tam JS; Read RC; Warren FC; Zambon M
Health Technol Assess; 2010 Dec; 14(55):193-334. PubMed ID: 21208550
[TBL] [Abstract][Full Text] [Related]
8. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
[TBL] [Abstract][Full Text] [Related]
9. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
[TBL] [Abstract][Full Text] [Related]
10. Predictive clinicopathological features derived from systematic autopsy examination of patients who died with A/H1N1 influenza infection in the UK 2009-10 pandemic.
Lucas S
Health Technol Assess; 2010 Dec; 14(55):83-114. PubMed ID: 21208548
[TBL] [Abstract][Full Text] [Related]
11. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.
Van Kerkhove MD; Hirve S; Koukounari A; Mounts AW;
Influenza Other Respir Viruses; 2013 Sep; 7(5):872-86. PubMed ID: 23331969
[TBL] [Abstract][Full Text] [Related]
12. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
[TBL] [Abstract][Full Text] [Related]
13. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
[TBL] [Abstract][Full Text] [Related]
14. Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians.
Booy R; Khandaker G; Heron LG; Yin J; Doyle B; Tudo KK; Hueston L; Gilbert GL; Macintyre CR; Dwyer DE
Med J Aust; 2011 Jan; 194(1):19-23. PubMed ID: 21449863
[TBL] [Abstract][Full Text] [Related]
15. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
[TBL] [Abstract][Full Text] [Related]
16. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic.
Chao DY; Cheng KF; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH; Chan WC; Hsieh YH;
Int J Infect Dis; 2011 Oct; 15(10):e695-701. PubMed ID: 21767970
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.
Tandale BV; Pawar SD; Gurav YK; Chadha MS; Koratkar SS; Shelke VN; Mishra AC
BMC Infect Dis; 2010 Aug; 10():255. PubMed ID: 20738878
[TBL] [Abstract][Full Text] [Related]
19. Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.
Makkoch J; Payungporn S; Prachayangprecha S; Tantilertcharoen R; Poovorawan Y
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):67-75. PubMed ID: 20527519
[TBL] [Abstract][Full Text] [Related]
20. Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.
Poeppl W; Poeppl G; Hunger M; Tobudic S; Winkler H; Faas A; Mooseder G; Burgmann H
J Med Virol; 2012 Sep; 84(9):1331-4. PubMed ID: 22825809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
